Lord, J. D., Long, S. A., Shows, D. M., Thorpe, J., Schwedhelm, K., Chen, J., . . . Buckner, J. H. (2018). Circulating Integrin Alpha4/Beta7+ Lymphocytes Targeted by Vedolizumab Have a Pro-Inflammatory Phenotype. Clin Immunol.

Lord, James D., S. Alice Long, Donna M. Shows, Jerill Thorpe, Katherine Schwedhelm, Janice Chen, Mariko Kita, και Jane H. Buckner. "Circulating Integrin Alpha4/Beta7+ Lymphocytes Targeted By Vedolizumab Have a Pro-Inflammatory Phenotype." Clin Immunol 2018.

Lord, James D., et al. "Circulating Integrin Alpha4/Beta7+ Lymphocytes Targeted By Vedolizumab Have a Pro-Inflammatory Phenotype." Clin Immunol 2018.